BRIEF-Adamas announces results of Ease Lid 3
September 20, 2016 at 16:55 PM EDT
* Announces results of Ease Lid 3, a pivotal trial of ADS 5102 for the treatment of Levodopa-induced Dyskinesia (lid) in parkinson's disease patients at the 4th world parkinson congress
